Shareholder lawsuit: delightful weapon against drug companies

The start of the tsunami of lawsuits against big pharma…….

Jon Rappoport's Blog

Shareholder lawsuit: delightful weapon against drug companies

by Jon Rappoport

May 24, 2017

The company is NewLink. The vaccine, or drug, depending on how it is defined, is called algenpantucel-L. A clinical trial of the drug recently failed to produce benefits in cancer patients, and the stock price of the company took a major dive.

A shareholder in NewLink, Rickey Ely, decided to sue.

His reasons are interesting, to say the least.

Clinical trials of new drugs seeking FDA approval go through four phases. The lawsuit states that phase 2 produced no encouraging results, violated standard protocol (there was no control group), and yet the company hyped the outcome of phase 2, and launched phase 3 only a few months after starting phase 2. Phase 3 shouldn’t have been initiated at all.

Owing to the company’s PR machine, shareholders were encouraged, but when phase 3 turned out to be…

View original post 317 more words

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s